Your browser doesn't support javascript.
loading
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study.
Monestier, Sandrine; Dalle, Stéphane; Mortier, Laurent; Dutriaux, Caroline; Dalac-Rat, Sophie; Meyer, Nicolas; Leccia, Marie Thérèse; Mansard, Sandrine; Montaudié, Henri; Saiag, Philippe; Combemale, Patrick; Guillot, Bernard; Skowron, François; Duval Modeste, Anne-Bénédicte; Bénéton, Nathalie; Hainaut, Ewa; Robert, Caroline; Arnault, Jean Philippe; Le Corre, Yannick; Jouary, Thomas; Ameur, Nabahet; Varey, Emilie; Khammari, Amir; Dréno, Brigitte.
Afiliação
  • Monestier S; AP-HM Dermatology Department, Hôpital de la Timone, Université Aix-Marseille, Marseille, France.
  • Dalle S; Lyon University, Cancerology Institute of Lyon Civic Hospital, Cancer Research Centre of Lyon, France.
  • Mortier L; Inserm U 1189, Dermatology Department, CHU de Lille, Lille University, Lille, France.
  • Dutriaux C; Dermatology Department, CHU de Bordeaux, Hôpital Saint André, Bordeaux, France.
  • Dalac-Rat S; Dermatology Department, CHU Dijon Bourgogne, CHU Le Bocage, Dijon, France.
  • Meyer N; Dermatology Department, Institut Universitaire du Cancer de Toulouse et CHU de Toulouse, Toulouse, France.
  • Leccia MT; Dermatology Department, CHU Albert Michalon, Grenoble, Université de Grenoble, Grenoble, France.
  • Mansard S; Dermatology Department, CHU Clermont-Ferrand, CHU Estaing, Clermont Ferrand, France.
  • Montaudié H; Dermatology Department, CHU Nice, Hôpital Archet 2, Nice, France.
  • Saiag P; General & Oncology Dermatology Department, Hôpital Ambroise Paré & EA4340, UVSQ, Boulogne-Billancourt.
  • Combemale P; Onco-dermatology Unit, Centre Léon Bérard, Lyon, France.
  • Guillot B; Dermatology Department, CHU Montpellier, Hôpital Saint-Eloi, Montpellier, France.
  • Skowron F; Dermatology Department, Hôpitaux Drôme Nord, Romans-sur-Isère, France.
  • Duval Modeste AB; Dermatology Department, CHU Rouen, Hôpital Charles Nicolle, Rouen, France.
  • Bénéton N; Dermatology Department, CH Le Mans, Le Mans, France.
  • Hainaut E; Dermatology Department, CHU de Poitiers, Poitiers, France.
  • Robert C; Oncology Department, Gustave Roussy and Paris-Sud University, Villejuif, France.
  • Arnault JP; Dermatology Department, CHU Amiens Picardie, Amiens, France.
  • Le Corre Y; Dermatology Department, CHU Angers, Angers, France.
  • Jouary T; Dermatology Department, Centre Hospitalier de Pau, Pau, France.
  • Ameur N; Medical Department, Immuno-oncology, Bristol-Myers Squibb Research, Rueil-Malmaison, France.
  • Varey E; Dermatology Department, CHU Nantes, Université Nantes, CIC 1413, CRCINA Inserm U1232, Nantes, France.
  • Khammari A; Dermatology Department, CHU Nantes, Université Nantes, CIC 1413, CRCINA Inserm U1232, Nantes, France.
  • Dréno B; Dermatology Department, CHU Nantes, Université Nantes, CIC 1413, CRCINA Inserm U1232, Nantes, France.
Int J Cancer ; 148(11): 2789-2798, 2021 06 01.
Article em En | MEDLINE | ID: mdl-33428772
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Nivolumabe / Melanoma Tipo de estudo: Observational_studies Limite: Aged / Aged80 / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Nivolumabe / Melanoma Tipo de estudo: Observational_studies Limite: Aged / Aged80 / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França